Strides Alathur's Chennai facility received a successful GMP inspection from USFDA.

Strides Alathur, a subsidiary of Strides Pharma Science, received an EIR from USFDA confirming successful GMP inspection at its Chennai facility. The April 1-5, 2024, inspection resulted in a "Voluntary Action Indicated" classification, benefiting their current and future product offerings in the US. The Alathur facility produces tablets and capsules, catering to the US and other regulated markets.

August 19, 2024
4 Articles